Increased Leukemic Epigenetic Plasticity and Pre-Treatment T-Cell Activation Predict Resistance to CD19 CAR T Cell Therapy in Pediatric Acute Lymphoblastic Leukemia

Presenter: Katherine E. Masih

Immunogenomic Approaches to Optimize Immunotherapeutic Targeting of Neuroblastoma

Presenter: Meijie Tian

Combined Immunogenomic and Immunopeptidomic Analyses Identified Biologically Relevant Immune Signatures and Novel Immunotherapy Targets in Osteosarcoma

Presenter: David Milewski

Identification of a First-in-Class KDM3B Inhibitor That Suppresses PAX3-FOXO1 Oncogene Activity in Fusion Positive Rhabdomyosarcoma

Presenter: Yong Yean Kim